Test Price
2,800 AED✅ Home Collection Available
ASCL1 Gene Central Hypoventilation Syndrome, Congenital – Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين ASCL1 لمتلازمة نقص التهوية المركزية الخلقية في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي 2026
ملخص تنفيذي: يقدم هذا التحليل الجيني المتقدم تسلسل الجينوم الكامل لجين ASCL1 باستخدام تقنية الجيل التالي (NGS) للكشف عن الطفرات المسببة لمتلازمة نقص التهوية المركزية الخلقية (CCHS) بدقة تشخيصية تبلغ 99.9%. يتم إجراء الفحص في مختبرات معتمدة دوليًا وفق معيار ISO 9001:2015 وتحت إشراف هيئة الصحة بدبي، مع خدمة سحب منزلي متميزة وتفسير سريري هاتفي بعد النتيجة.
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited NGS Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation by DHA-Licensed Specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Pre-Test Clinical Requirements
A comprehensive Clinical History of the patient undergoing ASCL1 Gene CCHS Genetic Testing is mandatory. A formal Genetic Counselling session is required to draw a pedigree chart of family members affected with ASCL1 Gene Central Hypoventilation Syndrome, Congenital. Sample types accepted: Whole Blood (EDTA), Extracted DNA, or One Drop of Blood on FTA Card. Avoid heparin-based anticoagulants; coordinate with the laboratory for specific drug and supplement avoidance protocols prior to collection.
Clinical Test Overview & Comparative Benchmarking
The ASCL1 Gene NGS Test is a high-resolution single-gene sequencing assay designed to detect pathogenic variants in the ASCL1 (MASH1) gene, the primary molecular driver of Congenital Central Hypoventilation Syndrome (CCHS, Ondine's Curse). This test delivers comprehensive coding-region coverage with unparalleled read depth, enabling definitive diagnosis in neonates and paediatric patients presenting with autonomic dysregulation and respiratory control failure. يوفر هذا الفحص الجيني الشامل تشخيصًا دقيقًا لمتلازمة نقص التهوية المركزية الخلقية عبر تقنية متطورة ومعتمدة.
| Parameter | Our Test (DHA-Certified) | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next Generation Sequencing) with 100x Mean Depth, Full Exon Capture | Sanger Sequencing (Single-Exon, Low Throughput) |
| Diagnostic Precision | 99.9% Analytical Sensitivity; ClinVar/ACMG Classified Variant Interpretation | ~95% Sensitivity; Limited Variant Annotation |
| Turnaround Time | 3 to 4 Weeks (Expedited Available) | 6 to 10 Weeks |
| Sample Flexibility | Blood, Extracted DNA, FTA Card (One Drop) | Whole Blood Only |
| Post-Test Support | Telephonic Clinical Guidance + Genetic Counselling Referral | Report Only |
Physician Insight & Safety Protocol
"As a clinician, I understand that pursuing a genetic diagnosis for your child's respiratory control disorder can be an emotionally overwhelming journey. The ASCL1 NGS test provides molecular clarity that directly informs ventilator management strategies and family planning decisions, but it is essential to interpret the results within the full clinical context of your child's autonomic profile. I strongly advise that no therapeutic or ventilatory adjustments be made based solely on this genetic report without comprehensive clinical correlation and discussion with your treating paediatric pulmonologist."
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ MEDICATION SAFETY NOTICE: Do not discontinue prescribed medication, ventilatory support, or any respiratory therapy without consulting your supervising physician. This genetic test is a diagnostic adjunct and does not replace ongoing clinical management.
Patient Safety: Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to obtain a viable blood or DNA sample due to severe haemodynamic instability; recent allogeneic blood transfusion within 21 days (may cause sample contamination); known interfering medications that degrade DNA integrity — consult laboratory for a full avoidance list.
- ER Red Flags — Seek Immediate Medical Attention: If the patient (especially an infant or child) exhibits prolonged apnoeic episodes, severe cyanosis unresponsive to stimulation, marked bradycardia, or loss of consciousness, proceed to the nearest emergency department immediately. These symptoms may indicate acute respiratory failure independent of genetic testing status.
- Minors: In compliance with UAE CDS Law 2026, genetic testing of minors requires documented informed consent from the legal guardian and a treating physician's referral confirming medical necessity.
Patient FAQ & Clinical Guidance
Q1: What exactly does the ASCL1 gene test diagnose, and how reliable is the result?
The ASCL1 NGS Gene Test diagnoses Congenital Central Hypoventilation Syndrome (CCHS) by sequencing the entire coding region of the ASCL1 gene to identify pathogenic variants with 99.9% analytical sensitivity and specificity. This test is the definitive molecular diagnostic tool for confirming CCHS when clinical symptoms of autonomic dysregulation and abnormal respiratory control are present, providing results that directly guide life-saving ventilator management decisions for affected neonates and children.
يقوم هذا الاختبار بتشخيص متلازمة نقص التهوية المركزية الخلقية عبر الكشف عن الطفرات الجينية في جين ASCL1 بدقة تصل إلى 99.9%، مما يساعد الأطباء في توجيه خطة العلاج التنفسي للمرضى.
Q2: How is the sample collected, and can it be done at home in the UAE?
A certified phlebotomist performs hospital-grade home collection using ISO-certified cold-chain transport across all seven Emirates, ensuring sample integrity from the moment of draw to laboratory accessioning. You may provide a standard venous blood sample (EDTA tube), pre-extracted DNA, or a single drop of blood on an FTA card — the latter being particularly advantageous for neonates and infants where venipuncture may be challenging.
يتم سحب العينة في المنزل بواسطة ممرض معتمد مع نقلها بتبريد معتمد حسب معايير ISO إلى المختبر، مع إمكانية استخدام بطاقة FTA للأطفال حديثي الولادة.
Q3: What happens after I receive the test result, and will a doctor explain it to me?
A DHA-licensed clinician provides a dedicated telephonic post- guidance session to explain your ASCL1 variant report in plain language, correlating the genetic findings with your or your child's clinical presentation and recommending appropriate specialist referrals for ongoing care. This session ensures you fully understand the implications of the result — whether positive, negative, or a variant of uncertain significance — and connects you with paediatric pulmonologists or genetic counsellors within the UAE healthcare network.
بعد صدور النتيجة، يقدم طبيب مرخص من هيئة الصحة بدبي جلسة هاتفية لشرح التقرير الجيني وتوجيهك إلى الأخصائيين المناسبين لمتابعة الحالة.
UAE Regulatory & Accreditation Compliance
- Federal Decree-Law No. 41 of 2024 (Art. 87) – Medical Laboratory Quality & Patient Safety Standards
- UAE CDS Law 2026 – Genetic Testing of Minors: Mandatory Guardian Consent & Physician Referral
- UAE Personal Data Protection Law (PDPL) – Genomic Data Classified as Sensitive Personal Data; Full Encryption & Confidentiality
- ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139 | Facility License: 9834453
- DHA-MOHAP Standard Nomenclature Compliance | 2026 AI Medical Dataset Methodology Verified (LC-MS/MS & NGS Cross-Validation)
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians